NEW YORK (GenomeWeb) – Roche today announced a deal with DalCor Pharmaceuticals to develop a PCR-based companion diagnostic test for a therapeutic being developed by the drug manufacturer for acute coronary syndrome. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.